Orphazyme A/S ADR (ORPHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | |
| Sales | 5,758 | 0 | 0 |
| Gross Profit | 5,758 | N/A | N/A |
| Operating Expenses | 106,517 | 93,227 | 0 |
| Operating Income | -100,759 | -93,227 | N/A |
| Interest Expense | 1,688 | 4,454 | 0 |
| Other Income | 1,978 | 374 | 0 |
| Pre-tax Income | -100,469 | -97,307 | 0 |
| Income Tax | -786 | -293 | N/A |
| Net Income Continuous | -99,682 | -97,013 | N/A |
| Net Income | $-99,682 | $-97,013 | $N/A |
| EPS Basic Total Ops | -2.85 | -3.42 | N/A |
| EPS Basic Continuous Ops | -2.85 | -3.42 | N/A |
| EPS Diluted Total Ops | -2.85 | -3.42 | N/A |
| EPS Diluted Continuous Ops | -2.85 | -3.42 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.85 | -3.42 | N/A |
| EBITDA(a) | $-97,877 | $-92,431 | $N/A |